SII Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per dose Roshni Dhar12 April 2023 11:21 AM ISTIn view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion...
Health Bulletin 11/April/2023 Roshni Dhar11 April 2023 4:34 PM ISTHere are the top health stories for the day:Weekly cases up 79% as Covid hits more statesIndia has observed the highest weekly count of COVID...
Serum Institute Covovax likely to be available at Rs 225 per dose on CoWIN portal Ruchika Sharma10 April 2023 2:00 PM ISTCovovax was granted emergency-use listing by the World Health Organization on December 17, 2021.
Pfizer, BioNTech dragged to Court over COVID vaccine patent infringement once again Ruchika Sharma6 April 2023 1:30 PM ISTUS: Arbutus Biopharma on Tuesday sued U.S. drugmaker Pfizer Inc. and its German partner BioNTech SE in a New Jersey district court, claiming...
COVID vaccine: SII seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults Ruchika Sharma4 April 2023 11:00 AM ISTCovovax is manufactured through technology transfer from US-based vaccine maker Novavax.
BioNTech plans to spend about USD 1 billion more on research this year Ruchika Sharma30 March 2023 10:00 AM ISTThe company said it expects to authorise new share buybacks worth up to $500 million this year, having already spent $1.3 billion on own shares...
High-risk people get COVID booster 12 months after last dose, recommends WHO Roshni Dhar29 March 2023 6:30 PM ISTThe World Health Organization (WHO) on Tuesday changed its recommendations for COVID-19 vaccines, suggesting that high-risk populations should receive...
Health Bulletin 29/March/2023 Roshni Dhar29 March 2023 4:41 PM ISTHere are the top health stories for the day:Soon, 2 years jail, Rs 50000 fine for attacking doctors in JharkhandIn stringent law on violence against...
Pfizer gets USFDA emergency use nod for Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma15 March 2023 12:15 PM ISTThe Pfizer-BioNTech COVID-19 Vaccines (COMIRNATY) are based on BioNTech's proprietary mRNA technology and were developed by both BioNTech and Pfizer.
Moderna loses bid to shift liability in COVID vaccine patent case Ruchika Sharma12 March 2023 1:15 PM ISTDespite the backing of the U.S. government, Moderna Inc on Friday failed to persuade a federal judge it should not have to face a patent lawsuit...
Pfizer, BioNTech submit application to USFDA for emergency use nod of Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma2 March 2023 4:15 PM ISTNew York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use...
Pfizer, BioNTech seek USFDA nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine for ages 12 years and older as primary series or booster Ruchika Sharma25 Feb 2023 12:30 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that they have submitted a supplemental Biologics License Application (sBLA) to the U.S....
